Vaxcyte, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PCVX, updated each market day.
PCVX AI Sentiment
AI predicts Vaxcyte, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Vaxcyte, Inc. Common Stock
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Sector
Exchange
Market Cap
$8,746,040,337
Cap Tier
Employees
507
Headquarters
SAN CARLOS, CA
Listed Since
June 12, 2020
Website
PCVX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PCVX Volatility
Vaxcyte, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
